2007
DOI: 10.1016/j.nbd.2007.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Early cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanol

Abstract: One of the most common causes of neurological disabilities are malformations of cortical development (MCD). A useful animal model of MCD consists of prenatal exposure to methylazoxymethanol (MAM), resulting in a postnatal phenotype characterized by cytological aberrations reminiscent of human MCD. Although postnatal effects of MAM are likely a consequence of prenatal events, little is known on how the developing brain reacts to MAM. General assumption is the effects of prenatally administered MAM are short liv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
23
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(25 citation statements)
references
References 51 publications
2
23
0
Order By: Relevance
“…However, in rats an administration of 7.5 mg/kg between GD 13 and 15 caused substantial changes in brain morphology (De Groot et al 2005). According to a study of Bassanini et al (2007), such a dose probably results in a fetal brain concentration of 30 µM, which is very similar to the effective concentrations in our rat in vitro results (EC 50 = 31.82 µM; Table 1), demonstrating that rNPCs were able to predict the actual risk of MAM properly.…”
Section: Discussionsupporting
confidence: 84%
“…However, in rats an administration of 7.5 mg/kg between GD 13 and 15 caused substantial changes in brain morphology (De Groot et al 2005). According to a study of Bassanini et al (2007), such a dose probably results in a fetal brain concentration of 30 µM, which is very similar to the effective concentrations in our rat in vitro results (EC 50 = 31.82 µM; Table 1), demonstrating that rNPCs were able to predict the actual risk of MAM properly.…”
Section: Discussionsupporting
confidence: 84%
“…This suggests a scenario where a “disease-primed” brain does not produce clinically relevant symptoms until the BBB is breached in the malformed region or near disease-prone neuronal circuits. This was repeatedly demonstrated in models of focal seizure disorders (e.g., methylazoxymethanol- or thalidomide-treated animals [57, 58]) or pilocarpine-treated animals or patients (26, 27, 36) where leakage of the BBB and hyperexcitability are commonly observed in the region of neuronal malformation or gliotic CNS region. Breakdown of BBB or “latency states” in the development of neurotransmitters may explain late onset of psychotic symptoms.…”
Section: Discussionmentioning
confidence: 86%
“…MAM is an anti-mitotic agent that can be administered to a pregnant dam via intraperitoneal injection, and passes though the placenta to damage the DNA in dividing cells of the fetal central nervous system [37]. Depending on the dose and timing of MAM administration, the severity and region of neural disruption can be modulated.…”
Section: Introductionmentioning
confidence: 99%